Stockreport

Unum Therapeutics Presents Preliminary Results from Ongoing Phase 1 Study ATTCK-20-03 at the 2018 ASH Annual Meeting

UNUM THERAPEUTICS INC COMMON  (UMRX) 
Last unum therapeutics inc common earnings: 3/26 07:30 am Check Earnings Report
PDF - Complete Responses Observed in Three of Six Patients at Dose Level 1 and One of Three Patients at Dose Level 2 - - No SAEs of Cytokine Release Syndrome or Neurologica [Read more]